89 related articles for article (PubMed ID: 3109794)
1. The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni.
Martinelli R; Pereira LJ; Rocha H
Clin Nephrol; 1987 May; 27(5):229-32. PubMed ID: 3109794
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
Martinelli R; Noblat AC; Brito E; Rocha H
Kidney Int; 1989 May; 35(5):1227-33. PubMed ID: 2504987
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
4. Current results in the clinical therapy of schistosomiasis mansoni.
Katz N
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
[No Abstract] [Full Text] [Related]
5. [Drug therapy of mansoni schistosomiasis].
Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of schistosomiasis mansoni].
de Carvalho SA
Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
[No Abstract] [Full Text] [Related]
7. Case 4-1996: paralysis due to schistosomiasis.
Cook J; Reich MR
N Engl J Med; 1996 Jun; 334(23):1548; author reply 1548-9. PubMed ID: 8618622
[No Abstract] [Full Text] [Related]
8. Case 4-1996: paralysis due to schistosomiasis.
Nishioka Sde A
N Engl J Med; 1996 Jun; 334(23):1548-9. PubMed ID: 8618623
[No Abstract] [Full Text] [Related]
9. Influence of specific treatment on the morbidity of Schistosomiasis mansoni in an endemic area of Minas Gerais, Brazil.
Conceicao MJ; Borges-Pereira J
Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):755-7. PubMed ID: 12219148
[TBL] [Abstract][Full Text] [Related]
10. Oxamniquine treatment for schistosomal polyposis: a 1-2 year follow-up study.
el-Masry NA; Farid Z; Bassily S; Kilpatrick ME; Watten RH; Girgis NI
J Trop Med Hyg; 1986 Feb; 89(1):19-21. PubMed ID: 3091853
[TBL] [Abstract][Full Text] [Related]
11. [Clinical, laparoscopic and histologic study of 60 patients with schistosomiasis mansoni].
Ruiz Pérez A; Ramos García A; Peláez Castro E; García Humarán G
Rev Cubana Med Trop; 1990; 42(2):231-9. PubMed ID: 2150995
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of glomerulopathy in schistosomiasis mansoni. Effect of corticosteroids, cyclophosphamide and schistosomicides].
Dutra M; de Carvalho Filho EM; Gusmão EA; Queiroz FP; Brito E; Rocha H
Rev Inst Med Trop Sao Paulo; 1979; 21(2):99-105. PubMed ID: 482773
[No Abstract] [Full Text] [Related]
13. On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine.
Costa G; Aguiar BG; Coelho PM; Cunha-Melo JR
Acta Trop; 2003 Dec; 89(1):13-6. PubMed ID: 14636977
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni: permanence of modulation of the granulomatous inflammatory response in mice cured in the chronic phase.
Coelho PM; Toppa NH; Feldmann JS; Gonçalves R; Mello RT
Int J Parasitol; 1996 Dec; 26(12):1393-5. PubMed ID: 9024890
[TBL] [Abstract][Full Text] [Related]
15. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine.
Conceição MJ; Argento CA; Corrêa A
Mem Inst Oswaldo Cruz; 2000; 95(3):375-80. PubMed ID: 10800196
[TBL] [Abstract][Full Text] [Related]
16. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study].
Chapadeiro E; Pitanga LC
Rev Soc Bras Med Trop; 1997; 30(1):53-6. PubMed ID: 9026832
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of oxamniquine in selective population chemotherapy in Ethiopia.
Birrie H; Abebe F; Ayele T
Ethiop Med J; 1995 Oct; 33(4):235-41. PubMed ID: 8674489
[TBL] [Abstract][Full Text] [Related]
18. Salmonella-S. mansoni association in patients with acquired immunodeficiency syndrome.
Lambertucci JR; Rayes AA; Gerspacher-Lara R
Rev Inst Med Trop Sao Paulo; 1998; 40(4):233-5. PubMed ID: 9876436
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression and parasitic diseases: experimental Schistosomiasis mansoni.
Gargione C; Vellosa SA; Hoshino-Shimizu S; Okumura M; Chiodelle SG
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(3):122-8. PubMed ID: 10436644
[TBL] [Abstract][Full Text] [Related]
20. Activity of known antischistosomal agents on early-developing forms of Schistosoma mansoni.
Pereira LH; Pellegrino J; Mello RT
J Parasitol; 1975 Apr; 61(2):249-52. PubMed ID: 805229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
